Bisphosphonates in Oncology: Focus on Clinical Experience with Pamidronate

ISSN： 1175-6357

Source： American Journal of Cancer, Vol.4, Iss.5, 2005-01, pp. : 293-305

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Practicalities and ethics of running clinical trials in paediatric oncology- the UK experience

By Estlin E.J. Ablett S.

European Journal of Cancer, Vol. 37, Iss. 11, 2001-07 ,pp. : 1394-1401

Elsevier

Access to resources Recommend Favorite

Why are patients with malignant lymphomas excluded from clinical trials? The experience of an oncology institute in Italy

By Serraino D. Zagonel V. Bordonaro R. Franceschi S.

European Journal of Cancer, Vol. 34, Iss. 3, 1998-02 ,pp. : 427-428

Elsevier

Access to resources Recommend Favorite

Bisphosphonates

By Body J.-J.

European Journal of Cancer, Vol. 34, Iss. 2, 1998-02 ,pp. : 263-269

Elsevier

Access to resources Recommend Favorite

Monoclonal Antibodies in Clinical Oncology

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 8, Iss. 5, 2008-06 ,pp. : 523-532

Bentham Science Publishers

Access to resources Recommend Favorite

The Chemistry of Bisphosphonates: From Antiscaling Agents to Clinical Therapeutics

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 12, Iss. 2, 2012-02 ,pp. : 95-101

Bentham Science Publishers

Access to resources Recommend Favorite